John P. Mistler

FDA investigator

Appears on 15 documents from 2015 to 2023, most often at sites in Massachusetts. Most often cites insanitary conditions (FDCA 501(a)(2)(A)).

15
Documents on file
5.7
Observations per 483
2015
First seen
2023
Most recent

What they cite most

From 85 observations

Activity by year

2015: 1, 2016: 3, 2017: 5, 2018: 2, 2019: 2, 2020: 1, 2023: 1

Where

Massachusetts 6 · Connecticut 4 · New Hampshire 3 · Maine 1 · Vermont 1

Is John P. Mistler coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

15 documents, newest first
FirmOpen
483 SCA Pharmaceuticals, LLCOct 20, 2023 · Windsor, Connecticut
483 Edge Pharma, LLCMar 30, 2020 · Colchester, Vermont
483 Avista Pharma Solutions, Inc. dbaDec 18, 2019 · Agawam, Massachusetts
483 Compounded Solu tions in PharmacyAug 29, 2019 · Monroe, Connecticut
483 Johnson Memorial Cancer CenterOct 19, 2018 · Enfield, Connecticut
483 Lynnfield Drug, Inc. dba Freedom Fertility PharmacyFeb 27, 2018 · Byf ield, Massachusetts
483 Anika Therapeutics IncSep 21, 2017 · Bedford, Massachusetts

About this profile

What does John P. Mistler inspect?

John P. Mistler appears on 15 documents on file covering 14 sites, most often in Massachusetts.

What do they cite most often?

FDCA 501(a)(2)(A) (insanitary conditions), followed by 21 CFR 211.42 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for John P. Mistler is dated Oct 20, 2023.